Doç. Dr. ABDULSAMET ERDEN

Yayın Ağı

Makaleler 244

1. Assessment of interstitial lung disease in systemic sclerosis using oscillometric methods: a novel approach to respiratory assessment.

Vasi İ., Karaduman İ., Alacaoğlu Ş., Duygulu S., Kardaş R. C., Yıldırım D., et al.

Rheumatology (Oxford, England) , 2025 (SCI-Expanded)

2. Behçet's disease beyond the criteria: insights from a tertiary centre in Turkey.

Firlatan Yazgan B., Sahin Mavi E. A., Kart Bayram G. S., Bulat B., Ekici M., Unaldi E., et al.

Clinical and experimental rheumatology , 2025 (SCI-Expanded)

3. Investigation of the pathogenic variants induced Sjogren's syndrome in Turkish population.

Terzi U., Ates I., Erden A., Suzen S., Irham L. M., Yilmaz S.

Open medicine (Warsaw, Poland) , cilt.20, sa.1, ss.20251294, 2025 (SCI-Expanded)

4. Prevalence, incidence and geographic distribution of familial Mediterranean fever in Turkey: a national cohort study.

Satiş H., Gül A., Ayan G., Babaoğlu H., Armağan B., Erden A., et al.

Clinical and experimental rheumatology , 2025 (SCI-Expanded)

5. Between diffuse and limited: the unique identity of systemic sclerosis–overlap syndromes

KÜÇÜK H., VASİ İ., KARADUMAN İ., ERDEN A.

Anatolian Current Medical Journal , cilt.7, sa.6, ss.913-918, 2025 (Hakemli Dergi)

6. Unfolding dermatological spectrum of Still's disease: a cohort study from the International AIDA Network Still's Disease Registry.

Calabrese L., D'Onghia M., Cartocci A., Hinojosa-Azaola A., Torres-Ruiz J., Lopalco G., et al.

Rheumatology (Oxford, England) , 2025 (SCI-Expanded)

7. A new characteristıc of systemic lupus erythematosus: subclinical vein involvement-an in-depth biochemical and imaging study.

Yildirim D., Erden A., Ibrahimkhanli N., Elefante E., Duran R., Kanik H. K., et al.

Rheumatology (Oxford, England) , 2025 (SCI-Expanded)

8. Vascular calcification in Takayasu arteritis: relationship with metabolic syndrome, left ventricular mass index, and intima-media thickness.

Karadeniz H., Kesen S., Akhan M. B., Unlu S., Kardas R. C., Guler A. A., et al.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese , cilt.85, ss.70-80, 2025 (SCI-Expanded)

9. Evolution of Clinical Characteristics and Treatment Strategies in Turkish SLE Patients Over Two Decades: A Retrospective Cohort Study

Kanik H. K., ERDEN A., Yildirim D., Kanik A. B., DURAN R., Kardas R. C., et al.

BRATISLAVA MEDICAL JOURNAL , cilt.126, sa.9, ss.2329-2336, 2025 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

10. Importance of potential prothrombotic state markers in Behçet's disease and correlation with vascular ultrasound.

Karadeniz H., Mammadov T., Cerit M. N., Kardas R. C., Guler A. A., Yıldırım D., et al.

Irish journal of medical science , cilt.194, sa.4, ss.1525-1532, 2025 (SCI-Expanded)

11. The relationship between disease activity, quality of life, and psychological status in patients with rheumatoid arthritis: A cross-sectional study

KARAKAŞ Ö., Ağır M., ERDEN A.

Ulusal Romatoloji Dergisi , cilt.17, sa.2, ss.85-91, 2025 (Hakemli Dergi)

12. Validity and reliability of the Turkish version of "The Occupational Circumstances Assessment Interview and Rating Scale" in rheumatic diseases

AKYÜREK G., BUMİN G., Onal G., Unal B., GÖKMEN D., ERDEN A., et al.

BRITISH JOURNAL OF OCCUPATIONAL THERAPY , cilt.88, sa.6, ss.344-351, 2025 (SCI-Expanded)

13. Is Myopenia or Myosteatosis Clinically Relevant in Systemic Sclerosis? Skeletal Muscle Assessment Using Computed Tomography.

Kılıç A. C., Vasi İ., Kılıç H. K., Erden A., Gündoğdu O., Kardaş R. C., et al.

Academic radiology , cilt.32, sa.6, ss.3574-3584, 2025 (SCI-Expanded, Scopus)

14. Choroidopathy in patients with systemic lupus erythematosus using enhanced depth imaging spectral domain optical coherence tomography and optical coherence tomography angiography

Bayuk E. G., Doguizi S., ERTEN Ş., Karakas O., Ozdal P. C.

INTERNATIONAL JOURNAL OF OPHTHALMOLOGY , cilt.18, sa.6, ss.1053-1063, 2025 (SCI-Expanded)

15. Is IgG4-Related Disease a Potential Risk Factor for Multiple Malignancies?

Duran R., Yıldırım D., Kardaş R. C., Vasi İ., Küçük H., Erden A.

International journal of rheumatic diseases , cilt.28, sa.5, 2025 (SCI-Expanded)

16. Serum Semaphorin 3A Levels in Patients with Behçet’s Disease with and without Vascular Involvement

Kayaalp M. Ç., ERDEN A., Karakaş Ö., Güven S. C., Armağan B., Kayaalp M., et al.

Bratislava Medical Journal , cilt.126, sa.5, ss.767-776, 2025 (SCI-Expanded)

17. Real-World Insights From Türkiye: Biologic DMARDs Usage in Spondyloarthritis Patients With Chronic Kidney Disease.

Bulut Gökten D., Tezcan M. E., Yağız B., Erden A., Kimyon G., Yaşar Bilge N. Ş., et al.

International journal of rheumatic diseases , cilt.28, sa.5, 2025 (SCI-Expanded)

18. Refractory Nodular Scleritis as a Presenting Sign of Colorectal Cancer.

Duran R., Kıran Y., Özdemir Yalçınsoy K., Bölek E. Ç., Erden A.

Ocular immunology and inflammation , ss.1-4, 2025 (SCI-Expanded)

19. PRDX-4: a novel biomarker similar to KL-6 for predicting the occurrence and progression of systemic sclerosis-ILD.

Alp G. T., Vasi İ., Alp E., Güler A. A., Karadeniz H., Gülbahar Ö., et al.

Biomarkers in medicine , ss.1-7, 2025 (SCI-Expanded)

20. Lupus and IgA nephropathy: coexistence or coincident?

Duran R., Yıldırım D., Can Kardaş R., Vasi İ., Kaya B., Çakır Y., et al.

Wiener klinische Wochenschrift , 2025 (SCI-Expanded)

21. Predicting extra-musculoskeletal and peripheral manifestations and their role on biologic treatment in patients with axial spondyloarthritis: TReasure experience

Durak Ediboglu E., KALYONCU U., Solmaz D., YAŞAR BİLGE N. Ş., Yılmaz S., Bes C., et al.

Archives of Rheumatology , cilt.40, sa.1, ss.1-14, 2025 (SCI-Expanded)

22. Serum CXCL-13 levels are associated with active neurological involvement in patients with systemic lupus erythematosus.

Yildirim D., Erden A., Fanouriakis A., Koc Kanik H., Babaoglu H., Kardas R. C., et al.

Lupus , 2025 (SCI-Expanded)

23. Intersecting Pathways: Moyamoya Syndrome and Antiphospholipid Antibodies—A Comprehensive Review of Clinical Insights, Therapeutic Considerations and Prospective Perspectives

VASİ İ., KARDAŞ R. C., TALAY K., YILDIRIM D., KAYA B., DURAN R., et al.

Acta Neurologica Scandinavica , cilt.2025, sa.1, 2025 (SCI-Expanded)

24. From Conventional to Advanced Therapies: A National Health Registry Report (2016-2022) on DMARDs in Rheumatoid Arthritis Treatment in Turkey

Ata N., Satis H., KÜÇÜKŞAHİN O., KARABULUT E., Ayan G., ERDEN A., et al.

BIOLOGICS-TARGETS & THERAPY , cilt.19, ss.331-339, 2025 (ESCI)

25. COVID-19 or systemic lupus erythematosus: Attention to similarity

ERDEN A., Karakas O., Ulusoy B. O., Gemcioglu E., İZDEŞ S., Guner R., et al.

REVISTA ROMANA DE MEDICINA DE LABORATOR , cilt.33, sa.1, ss.59-64, 2025 (SCI-Expanded)

26. Obstruktif Uyku Apne Sendromu Tanılı Hastalarda Hematolojik Parametrelerin Değerlendirilmesi; Tek Merkez Deneyimi

USLU E., ERDEN A., BOL O., karagöz h.

Journal of Anatolian Medical Research , cilt.9, sa.3, ss.102-106, 2024 (Hakemli Dergi)

27. TOFACITINIB: CURRENT CONSIDERATIONS IN THE MANAGEMENT OF IMMUNE INFLAMMATORY DISORDERS

Erden A.

Rheumatology Quarterly , cilt.2, sa.4, ss.158-162, 2024 (Hakemli Dergi)

28. Is the visceral adiposity index associated with the presence of cardiovascular risk scores and comorbidity in psoriatic disease?

OMMA A., ERDEN F., ÇOLAK S., Can Sandıkçı S., OMMA T., KASIM İ., et al.

Ulusal Romatoloji Dergisi , cilt.16, sa.3, ss.90-96, 2024 (Hakemli Dergi)

29. Nationwide study on the prevalence of rheumatoid factor and anticitrullinated peptide positivity and their contribution to rheumatoid arthritis diagnosis.

Satiş H., Erden A., Bilgin E., Ayan G., Armağan B., Tecer D., et al.

Turkish journal of medical sciences , cilt.54, sa.5, ss.949-955, 2024 (SCI-Expanded)

30. Assessment of venous disease with different venous disease specific scales in Behçet's disease patients with deep vein thrombosis.

Aksoy A., Colak S., Yagiz B., Coskun B. N., Omma A., Sarı A., et al.

Phlebology , cilt.39, sa.8, ss.550-556, 2024 (SCI-Expanded)

31. Kolorektal kanserli hastaların demografik özellikleri

KARAKAŞ Ö., ERDEN A., aydın isak ö., İMAMOĞLU G. İ., KAYHAN S.

Turkish Journal of Clinics and Laboratory , cilt.15, sa.3, ss.376-382, 2024 (Hakemli Dergi)

32. Baseline capillaroscopy provides no evidence of microvascular changes to predict long-COVID syndrome.

Ulusoy B. O., Babaoglu H., Aypak B. A. A., Akinci E., Kucuksahin O., Erten A. O. S., et al.

Bratislavske lekarske listy , 2024 (SCI-Expanded)

33. Calcineurin inhibitors in unplanned pregnancies with active lupus disease: A retrospective observational study.

Vasi İ., Yıldırım D., Kardaş R. C., Kaya B., Duran R., Alp G. T., et al.

International journal of clinical pharmacology and therapeutics , cilt.62, sa.7, ss.326-333, 2024 (SCI-Expanded, Scopus)

34. Unveiling cancer risk in ANCA-associated vasculitis: result from the Turkish Vasculitis Study Group (TRVaS).

Bilgin E., Demirci Yıldırım T., Özdemir Ulusoy B., Öğüt T. S., Karabacak M., Sadioğlu Çağdaş Ö., et al.

Internal and emergency medicine , cilt.19, sa.4, ss.1025-1034, 2024 (SCI-Expanded, Scopus)

35. Assessment and comparison of the 2023 ACR/EULAR APS criteria with the revised Sapporo criteria.

Vasi İ., Kardaş R. C., Ekici M., Yıldırım D., Kaya B., Duran R., et al.

International journal of rheumatic diseases , cilt.27, sa.5, 2024 (SCI-Expanded, Scopus)

36. Coronavirus Disease 2019 Outcomes in Amyloid A Protein Amyloidosis Secondary to Rheumatic Conditions and Signs of Post- Coronavirus Disease 2019 Proteinuria Progression.

Güven S. C., Erden A., Küçük H., Apaydın H., Polat B., Kardaş R. C., et al.

European journal of rheumatology , cilt.11, sa.1, ss.2-7, 2024 (ESCI)

37. The burden of face affected questionnaire in patients with systemic sclerosis: Translation, cross-cultural adaptation and psychometric properties in the Turkish version

Sari F., Apaydin Z. B., Apaydin H. A., Kayaalp M., ERDEN A., Güven S. C., et al.

Egyptian Rheumatologist , cilt.46, sa.2, ss.56-61, 2024 (ESCI)

38. Low relapse rate in patients with giant cell arteritis in a multi-centre retrospective Turkish Registry.

Alibaz-Öner F., Kelesoglu B., Balci M. A., Yardimci G. K., Armağan B., Kiliç L., et al.

Clinical and experimental rheumatology , cilt.42, sa.4, ss.816-821, 2024 (SCI-Expanded)

39. Non-criteria autoantibodies in antiphospholipid syndrome may be associated with underlying disease activity.

Akyüz Dağlı P., Erden A., Babaoğlu H., Karakaş Ö., Özdemir Ulusoy B., Konak H. E., et al.

Irish journal of medical science , cilt.193, sa.2, ss.1099-1107, 2024 (SCI-Expanded)

40. Reliability and validity of the Turkish version of Scleroderma Skin Patient-Reported Outcome in patients with systemic sclerosis

Sari F., Bazancir Apaydin Z., Apaydin H., Kayaalp M., ERDEN A., Güven S. C., et al.

Archives of Rheumatology , cilt.39, sa.1, ss.52-59, 2024 (SCI-Expanded)

41. Colchicine-intolerant familial mediterranean fever patients: A comparative study between different colchicine doses and IL-1 inhibitor monotherapy.

Yildirim D., Kardas R. C., Gun M., Kaya B., Vasi I., Duran R., et al.

International immunopharmacology , cilt.128, ss.111491, 2024 (SCI-Expanded, Scopus)

42. Is compressed colchicine tablet superior to other colchicine preparations in patients with familial Mediterranean fever?

Vasi İ., Kardaş R. C., Yıldırım D., Kaya B., Duran R., Karadeniz H., et al.

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS , cilt.62, ss.77-82, 2024 (SCI-Expanded, Scopus)

43. Tocilizumab as a first line biologic agent in rheumatoid arthritis patients with inadequate response to disease-modifying anti-rheumatic drugs: real life experience from the TReasure Registry.

Karadag O., Farisogullari B., Yagiz B., Erden A., Ademoglu Z., Kimyon G., et al.

Clinical and experimental rheumatology , cilt.42, ss.130-137, 2024 (SCI-Expanded)

44. Clinical characteristics and disease course before and after SARS-CoV-2 infection in a large cohort of systemic sclerosis patients.

AVANOĞLU GÜLER A., ÖZÇİMEN B., Aydoğdu M. S., Sari A., Numune A., TÜZÜN ERSAN N., et al.

Turkish journal of medical sciences , cilt.54, sa.1, ss.76-85, 2023 (SCI-Expanded)

45. The predictors of paradoxical reactions especially psoriasis with biologic therapy from the TReasure database: a 5-year follow-up study.

Yagiz B., Lermi N., Coskun B. N., Dalkilic E., Kiraz S., Erden A., et al.

Rheumatology (Oxford, England) , cilt.62, ss.3962-3967, 2023 (SCI-Expanded, Scopus)

46. Semaphorin 3A levels in vascular and nonvascular phenotypes in systemic sclerosis.

Kayaalp M., Erden A., Apaydin H., Güven S. C., Armağan B., Cağlayan Kayaalp M., et al.

Laboratory medicine , cilt.54, ss.646-651, 2023 (SCI-Expanded, Scopus)

47. Could serum HMGB1 levels be a predictor associated with psoriatic arthritis?

Yildirim D., Baykul M., Edek Y. C., Gulengul M., Alp G. T., Eroglu F. S., et al.

BIOMARKERS IN MEDICINE , cilt.17, sa.20, ss.871-880, 2023 (SCI-Expanded, Scopus)

48. Diffuse generalized venulitis as the primary pathology of Behçet's disease: A comprehensive magnetic resonance venography study.

Karadeniz H., Ucar M., Mammadov T., Mirzayeva L. S., Guler A. A., Kardas R. C., et al.

Seminars in arthritis and rheumatism , cilt.62, ss.152246, 2023 (SCI-Expanded, Scopus)

49. HCV-related cryoglobulinemic vasculitis/Cryoglobulinemic vasculitis: Definition based on Chapel Hill Conference Consensus 2012 and case report

ÖZDEMİR B., ERDEN A.

Acta Medica , cilt.54, sa.1, ss.46-49, 2023 (Hakemli Dergi)

50. Epidemiological characteristics of hepatitis B and C in patients with inflammatory arthritis: Implications from treasure database

Ersözlü E. D., EKİCİ M., COŞKUN B. N., Badak S. Ö., BİLGİN E., KALYONCU U., et al.

Archives of Rheumatology , cilt.38, sa.3, ss.347-357, 2023 (SCI-Expanded)

51. The outcome of COVID-19 in patients with autoimmune rheumatic diseases: Comparable to the general population or worse?

Batu E. D., Erden A.

International journal of rheumatic diseases , cilt.26, sa.8, ss.1435-1439, 2023 (SCI-Expanded, Scopus)

52. Long-Term Results of Immunogenicity of Booster Vaccination against SARS-CoV-2 (Hybrid COV-RAPEL TR Study) in Turkiye: A Double-Blind, Randomized, Controlled, Multicenter Phase 2 Clinical Study.

Ates I., Batirel A., Aydin M., Karadag F. Y., Erden A., Kucuksahin O., et al.

Vaccines , cilt.11, sa.7, 2023 (SCI-Expanded, Scopus)

53. Sonoelastography and S100 proteins in the differential diagnosis of IgG4-related disease (IgG4-RD)

Karadeniz H., Yılmaz Demirci N., Cerit M. N., Allahverdiyeva S., Paşaoğlu H., Karaoğlan A., et al.

Ulusal Romatoloji Dergisi , cilt.15, sa.2, ss.73-81, 2023 (Scopus)

54. Serum triggering receptor expressed on myeloid cells-1 (TREM-1) levels may be associated with disease activity in patients with familial Mediterranean fever

YILDIRIM D., avcu a., erdoğan e., ERDEN A., KÜÇÜK H.

Ulusal Romatoloji Dergisi , cilt.15, sa.2, ss.67-72, 2023 (Scopus)

55. Rituximab use may indicate impaired quality of life in granulomatosis with polyangiitis

AKYÜZ DAĞLI P., GÜVEN S. C., ERDEN A., eskin M. A., ARMAĞAN B., KÜÇÜKŞAHİN O., et al.

Ulusal Romatoloji Dergisi , cilt.15, sa.2, ss.53-59, 2023 (Scopus)

56. COVID-19 disease frequency, risk factors, and re-infection rates in patients with autoimmune rheumatic disease receiving rituximab.

Armağan B., Konak H. E., Özdemir B., Apaydın H., Atalar E., Akyüz Dağlı P., et al.

International journal of rheumatic diseases , cilt.26, sa.5, ss.930-937, 2023 (SCI-Expanded, Scopus)

57. Clinical and laboratory factors associated with the bamboo spine in patients with axial spondyloarthritis: are there clues for the bamboo spine?

Atagündüz P., Kiraz S., Akar S., Küçükşahin O., Erden A., Aksoy A., et al.

Clinical and experimental rheumatology , cilt.41, ss.620-627, 2023 (SCI-Expanded, Scopus)

58. Mortality in psoriatic arthritis patients, changes over time, and the impact of COVID-19: results from a multicenter Psoriatic Arthritis Registry (PsART-ID).

Erden A., Ayan G., Kilic L., Solmaz D., Bakirci S., Kimyon G., et al.

Clinical rheumatology , cilt.42, ss.385-390, 2023 (SCI-Expanded, Scopus)

59. EFFICACY AND SAFETY OF TOFACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS

Bayram D., ERDEN A., kart bayram g. s., BAŞER S., ERTEN Ş.

Middle Black Sea Journal of Health Science , cilt.9, sa.1, ss.50, 2023 (Hakemli Dergi)

60. Evaluation of patients with antiphospholipid syndrome subsequently COVID-19 vaccinations: A retrospective cohort study

Karakaş Ö., Erden A., Armağan B., Güven S. C., Atalar E., Polat B., et al.

International Journal of Rheumatic Diseases , cilt.26, sa.2, ss.292-297, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

61. Tofacitinib experience in patients with enteropathic arthritis.

Dağlı P. A., Erden A., Güven S. C., Armağan B., Yürekli Ö. T., Özin Y. Ö., et al.

Immunotherapy , cilt.15, ss.619-626, 2023 (SCI-Expanded, Scopus)

62. Pulmonary hypertension in Behçet’s disease: echocardiographic screening and multidisciplinary approach

Armağan B., Okşul M., ŞENER Y. Z., Sari A., Erden A., Yardimci G. K., et al.

Turkish Journal of Medical Sciences , cilt.53, sa.2, ss.563-571, 2023 (SCI-Expanded, Scopus, TRDizin)

63. The Possible Relation of Demodex and Facial Erythema in Connective Tissue Diseases

Erden A., Armağan B., Güven S. C., Karakaş Ö., Erden F., Özdemir B., et al.

Iranian Journal of Parasitology , cilt.18, sa.2, ss.237-243, 2023 (SCI-Expanded)

64. The impact of antiphospholipid antibodies in Takayasu arteritis

Firat Şentürk E., Erden A., Sari A., Armağan B., KILIÇ L., KALYONCU U., et al.

Turkish Journal of Medical Sciences , cilt.53, sa.1, ss.199-205, 2023 (SCI-Expanded, Scopus, TRDizin)

65. Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center

Armağan B., Atalar E., Güven S. C., Özdemir B., Konak H. E., Akyüz Dağlı P., et al.

Immunopharmacology and Immunotoxicology , cilt.45, sa.4, ss.395-401, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

66. A SINGLE-CENTER RHEUMATOLOGY EXPERIENCE OF SARCOIDOSIS: OBSERVATIONS FROM 70 PATIENTS

Konak H. E., Guven S. C., Atalar E., Dagli P. A., Ulucakoy R., Erdogan E. K., et al.

SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES , cilt.40, sa.3, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

67. Derivation and validation of adult Still Activity Score (SAS)

Kalyoncu U., Kasifoglu T., Omma A., Bes C., Cinar M., Emmungil H., et al.

Joint Bone Spine , cilt.90, sa.1, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

68. Effects of breast milk on Behçet’s disease clinical features

Konak H. E., Erden A., Armağan B., Güven S. C., Apaydin H., Dağli P. A., et al.

Turkish Journal of Medical Sciences , cilt.53, sa.1, ss.121-129, 2023 (SCI-Expanded, Scopus, TRDizin)

69. Ustekinumab in enteropathic arthritis.

Ulusoy B. Ö., Erden A., Güven S. C., Armağan B., Yürekli Ö. T., Özin Y. Ö., et al.

Immunotherapy , cilt.15, ss.583-592, 2023 (SCI-Expanded, Scopus)

70. Effects of COVID-19 on axial spondyloarthritis disease flare

ARMAĞAN B., ATALAR E., ÖZDEMİR B., KARAKAŞ Ö., KAYACAN ERDOĞAN E., GÜVEN S. C., et al.

GULHANE MEDICAL JOURNAL , cilt.64, ss.301-306, 2022 (Scopus) Sürdürülebilir Kalkınma

71. Restless leg syndrome and sleep quality in granulomatosis with polyangiitis

GÜVEN S. C., AKYÜZ DAĞLI P., Karacaoğlu S., ARMAĞAN B., ERDEN A., KÜÇÜKŞAHİN O., et al.

Ulusal Romatoloji Dergisi , cilt.14, sa.3, ss.124-130, 2022 (Scopus)

72. Effectiveness and safety of tofacitinib in rheumatoid arthritis-associated interstitial lung disease: TReasure real-life data

KALYONCU U., BİLGİN E., Erden A., SATIŞ H., TUFAN A., Tekgöz E., et al.

Clinical and Experimental Rheumatology , cilt.40, sa.11, ss.2071-2077, 2022 (SCI-Expanded, Scopus)

73. Tuberculin skin test before biologic and targeted therapies: does the same rule apply for all?

İlgen U., KARADAĞ Ö., EMMUNGİL H., KÜÇÜKŞAHİN O., Koca S. S., Erden A., et al.

Rheumatology International , cilt.42, sa.10, ss.1797-1806, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

74. Recurrent Aphthous Stomatitis and Related Factors in Turkish Adult Population: A Striking Outcome of Cappadocia Chronic Diseases Epidemiological Study

ÇALIK BAŞARAN N., KALYONCU U., KARADAĞ Ö., AKDOĞAN A., ERDEN A., KILIÇ L., et al.

Cumhuriyet Tıp Dergisi (ELEKTRONİK) , cilt.44, sa.3, ss.233-238, 2022 (Hakemli Dergi)

75. Effects of anti-SARS-CoV-2 vaccination on safety and disease exacerbation in patients with Behçet syndrome in a monocentric cohort

Apaydin H., Erden A., Güven S. C., Armağan B., Konak H. E., Polat B., et al.

International Journal of Rheumatic Diseases , cilt.25, sa.9, ss.1068-1077, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

76. Performance of the systemic lupus erythematosus risk probability index in a cohort of undifferentiated connective tissue disease

Erden A., Apaydın H., Fanouriakis A., Güven S. C., Armagan B., Akyüz Dağlı P., et al.

Rheumatology (Oxford, England) , cilt.61, sa.9, ss.3606-3613, 2022 (SCI-Expanded, Scopus)

77. Clinical course of idiopathic inflammatory myopathies in the COVID-19 pandemic: a single-center experience

Apaydin H., Erden A., Güven S. C., Armağan B., Karakaş Ö., Özdemir B., et al.

Future Virology , cilt.17, sa.8, ss.545-556, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

78. A single-center COVID-19 vaccine experience with CoronaVac and BNT162b2 in familial Mediterranean fever patients

Güven S. C., Karakaş Ö., Atalar E., Konak H. E., Akyüz Dağlı P., Kayacan Erdoğan E., et al.

International Journal of Rheumatic Diseases , cilt.25, sa.7, ss.787-794, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

79. Metabolic syndrome is associated with increased cardiovascular risk and disease damage in patients with Takayasu arteritis

Sağlam B., Kaymaz-Tahra S., Kenar G., Kocaer S., Omma A., Erden A., et al.

International Journal of Rheumatic Diseases , cilt.25, sa.7, ss.775-780, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

80. Intravenous Treatment Adherence of Patients with Chronic Inflammatory Rheumatic Diseases During the COVID-19 Pandemic: Experience of a Single Center

Konak H. E., ARMAĞAN B., GÜVEN S. C., ATALAR E., KARAKAŞ Ö., ESMER S., et al.

ROMANIAN JOURNAL OF INTERNAL MEDICINE = REVUE ROUMAINE DE MEDECINE INTERNE , cilt.0, 2022 (ESCI, Scopus) Sürdürülebilir Kalkınma

81. Semaphorin 3A Levels in Lupus with and without Secondary Antiphospholipid Antibody Syndrome and Renal Involvement

Bayram G. S. K., Erden A., Bayram D., Özdemir B., Karakaş Ö., Apaydln H., et al.

Lab Medicine , cilt.53, sa.3, ss.285-289, 2022 (SCI-Expanded, Scopus)

82. Secukinumab in the treatment of psoriatic arthritis or ankylosing spondyloarthritis with multiple sclerosis: A case series with literature review

Eksin M. A., Erden A., Güven S. C., Armagan B., Ozdemir B., Karakas O., et al.

Immunotherapy , cilt.14, sa.6, ss.401-408, 2022 (SCI-Expanded, Scopus)

83. Comprehensive assessment and outcomes of patients with chronic periaortitis

Yardimci G., Düzgün S. A., Farisogullari B., Bolek E., ELDEM F. G., Erden A., et al.

Clinical and Experimental Rheumatology , cilt.40, sa.4, ss.801-810, 2022 (SCI-Expanded, Scopus)

84. Antineutrophil cytoplasmic antibody positivity and clinical implications in COVID-19

Güven S. C., Apaydln H., Özdemir B., Armaǧan B., Ateş I., Erden A., et al.

Future Virology , cilt.17, sa.4, ss.239-245, 2022 (SCI-Expanded) Sürdürülebilir Kalkınma

85. Evaluation of Coronavirus Disease-2019 Patients with Nailfold Capillaroscopy

ARMAĞAN B., ÖZDEMİR B., AYPAK A., AKINCI E., KARAKAŞ Ö., GÜVEN S. C., et al.

Namık Kemal Medical Journal , cilt.10, sa.1, ss.80-86, 2022 (Hakemli Dergi) Sürdürülebilir Kalkınma

86. Physicians' Biological Drug Preference in Patients with Rheumatoid Arthritis and Spondyloarthritis with a History of Malignancy: Perspectives from the Treasure Database

Tekgoz E., Colak S., Yardimci K. G., KÜÇÜKŞAHİN O., Cinar M., Yilmaz S., et al.

Journal of Clinical Rheumatology , cilt.28, sa.2, 2022 (SCI-Expanded, Scopus)

87. COVID-19 in patients with Behçet's disease: Outcomes and rate of Behçet's exacerbations in a retrospective cohort

Polat B., Erden A., Güven S. C., Armaǧan B., Karakaş Ö., Özdemir B., et al.

Modern Rheumatology , cilt.32, sa.2, ss.455-459, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

88. The clinical significance of antiphospholipid antibodies in COVID-19 infection

Atalar E., Erden A., Guven S. C., Armagan B., Ates İ., KÜÇÜKŞAHİN O., et al.

Journal of Infection in Developing Countries , cilt.16, sa.2, ss.276-282, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

89. Pregnancy in Takayasu’s arteritis has a high risk of hypertension-related fetomaternal complications: A retrospective study of a Turkish cohort

Gönenli M. G., Kaymaz Tahra S., Kara M., Keser G., YAZICI A., Erden A., et al.

International Journal of Rheumatic Diseases , cilt.25, sa.2, ss.140-146, 2022 (SCI-Expanded, Scopus)

90. Comparison of APACHE II scores and mortality with CRP/albumin, neutrophil/lymphocyte and thrombocyte/lymphocyte ratios in patients admitted to internal medicine and anesthesia reanimation intensive care unit

Usta A., Gemcioglu E., Baser S., Ersoy O., Polat Y. H., Erden A., et al.

Journal of Laboratory Medicine , cilt.46, sa.1, ss.23-31, 2022 (Scopus) Sürdürülebilir Kalkınma

91. Hydroxychloroquine shortened hospital stay and reduced intensive care unit admissions in hospitalized COVID-19 patients

Omma A., Erden A., Apaydin H., Aslan M., Çamli H., Şahiner E. S., et al.

Journal of Infection in Developing Countries , cilt.16, sa.1, ss.25-31, 2022 (SCI-Expanded, Scopus)

92. Reducing length of hospital stay with colchicines

Karakaş Ö., Erden A., Güven S. C., Armaǧan B., Sahiner E. S., Kurtipek A. C., et al.

Journal of Infection in Developing Countries , cilt.16, sa.1, ss.57-62, 2022 (SCI-Expanded, Scopus)

93. An evaluation of the results of convalescent plasma therapy applied to pregnant women diagnosed as COVID-19-positive in a pandemic center: A prospective cohort study

Erol S. A., Tanaçan A., Apaydin H., Göncü Ayhan Ş., Oluklu D., Uyan Hendem D., et al.

Turkish Journal of Medical Sciences , cilt.52, sa.3, ss.554-564, 2022 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

94. COVID-19 course in granulomatosis with polyangiitis: single center experience with review of the literature

Armağan B., Eksin M. A., Güven S. C., Özdemir B., Akyüz Dağli P., KÜÇÜKŞAHİN O., et al.

Turkish Journal of Medical Sciences , cilt.52, sa.4, ss.899-909, 2022 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

95. Safety and immunogenicity of inactive vaccines as booster doses for COVID-19 in Türkiye: A randomized trial

Omma A., Batirel A., Aydin M., Yilmaz Karadag F., Erden A., KÜÇÜKŞAHİN O., et al.

Human Vaccines and Immunotherapeutics , cilt.18, sa.6, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

96. Comparison of anakinra and tocilizumab in management of severe COVID-19: a retrospective cohort study

KÜÇÜKŞAHİN O., Erden A., Karakaş Ö., Güven S. C., Armağan B., Şahiner E. S., et al.

Turkish Journal of Medical Sciences , cilt.52, sa.5, ss.1486-1494, 2022 (SCI-Expanded, Scopus, TRDizin)

97. COVID-19 outcomes in patients with antiphospholipid syndrome: a retrospective cohort study

Erden A., Karakas O., Armagan B., Guven S., Ozdemir B., Atalar E., et al.

Bratislava Medical Journal , cilt.123, sa.2, ss.120-124, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

98. Budd-Chiari syndrome in Behcet's disease: a retrospective multicenter study

Akyol L., Toz B., Bayindir O., Zengin O., Cansu D., Yigit M., et al.

CLINICAL RHEUMATOLOGY , cilt.41, sa.1, ss.177-186, 2022 (SCI-Expanded, Scopus)

99. COVID-19-Associated Cerebral Venous Sinus Thrombosis: A Case Report and Review of the Literature

AYPAK A., AKINCI E., ERDEN A., Çakır Topçu B., KÜÇÜKŞAHİN O., GÜNER H. R.

Mediterranean Journal of Infection, Microbes and Antimicrobials , cilt.10, sa.63, 2021 (Scopus) Sürdürülebilir Kalkınma

100. Brescia-COVID Respiratory Severity Scale (BRCSS) and Quick SOFA (qSOFA) score are most useful in showing severity in COVID-19 patients

San I., Gemcioglu E., BAŞER S., Yilmaz Cakmak N., Erden A., İZDEŞ S., et al.

Scientific Reports , cilt.11, sa.1, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

101. Should timing be considered before abandoning convalescent plasma in covid-19? Results from the Turkish experience

Ateş İ., Erden A., Güven S. C., Gürler E. K., Çağlayan A., Güçbey Ö., et al.

Transfusion and Apheresis Science , cilt.60, sa.6, 2021 (SCI-Expanded, Scopus)

102. Endocan: A Novel Marker for Colchicine Resistance in Familial Mediterranean Fever Patients?

Omma A., Armaǧan B., Güven S. C., Sandıkçı S. C., Çolak S., Yücel Ç., et al.

Frontiers in Pediatrics , cilt.9, 2021 (SCI-Expanded, Scopus)

103. In the era of disease-modifying antirheumatic drugs, how close are we to treating rheumatoid arthritis without the use of glucocorticoids?

YAĞIZ B., COŞKUN B. N., PEHLİVAN Y., DALKILIÇ H. E., KİRAZ S., YAZISIZ V., et al.

Rheumatology International , cilt.41, sa.11, ss.1915-1924, 2021 (SCI-Expanded, Scopus)

104. Compliance to not only prone but also lateral and supine positioning improves outcome in hospitalised COVID-19 patients

Ateş İ., Erden A., Gürler E. K., Çağlayan A., Güçbey Ö., Karakaş Ö., et al.

International Journal of Clinical Practice , cilt.75, sa.11, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

105. Predictors for the risk and severity of post-thrombotic syndrome in vascular Behcet's disease

AKSOY A., Colak S., Yagiz B., COŞKUN B. N., Omma A., YILDIZ Y., et al.

JOURNAL OF VASCULAR SURGERY-VENOUS AND LYMPHATIC DISORDERS , cilt.9, sa.6, ss.1451-1459, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

106. Can anticarbamylated protein antibodies be used to support the diagnosis of systemic lupus erythematosus?

Özdemir B., Erden A., Erten A., Yeşil T. H., Allşlk M., KÜÇÜKŞAHİN O.

Biomarkers in Medicine , cilt.15, sa.14, ss.1253-1260, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

107. Prevalence of sarcopenia and clinical implications in patients with newly diagnosed rheumatoid arthritis

Ekici R., Erden A., Güven S. C., Armağan B., Özdemir B., Karakaş Ö., et al.

Nutrition , cilt.90, 2021 (SCI-Expanded, Scopus)

108. A single center experience of intravenous immunoglobulin treatment in Covid-19

Omma A., Erden A., Armağan B., Güven S. C., Karakaş Ö., Şahiner E. S., et al.

International Immunopharmacology , cilt.98, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

109. Comment on: What is the meaning of ANCA positivity in IgG4-related disease?

Apaydin H., Armaǧan B., Güven S. C., Omma A., KÜÇÜKŞAHİN O., Erden A.

Rheumatology (Bulgaria) , cilt.60, sa.9, 2021 (Scopus)

110. COVID-19 and eosinophilic granulomatosis with polyangiitis or COVID-19 mimicking eosinophilic granulomatosis with polyangiitis?

Özdemir B., Erden A., Güven S. C., Armagan B., Apaydin H., Karakas Ö., et al.

Rheumatology International , cilt.41, sa.8, ss.1515-1521, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

111. Uveitis-related Factors in Patients With Spondyloarthritis: TReasure Real-Life Results

Yaşar Bilge N. Ş., Kalyoncu U., Atagündüz P., Dalkılıç E., Pehlivan Y., Küçükşahin O., et al.

American Journal of Ophthalmology , cilt.228, ss.58-64, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

112. Biological and targeted-synthetic disease-modifying antirheumatic drugs with concomitant methotrexate or leflunomide in rheumatoid arthritis: Real-life TReasure prospective data

Kimyon G., KALYONCU U., KİRAZ S., Bes C., COŞKUN N. F., YAĞIZ B., et al.

Clinical and Experimental Rheumatology , cilt.39, sa.4, ss.852-858, 2021 (SCI-Expanded)

113. Association of disease characteristics with the temporal sequence of skin and musculoskeletal disease onset in psoriatic arthritis

Tascilar K., Bayindir O., Dogru A., Tinazzi I., Kimyon G., Ozisler C., et al.

BRITISH JOURNAL OF DERMATOLOGY , cilt.184, ss.1202-1203, 2021 (SCI-Expanded)

114. Predictive values of biochemical markers as early indicators for severe COVID-19 cases in admission

Gemcioglu E., Davutoglu M., Catalbas R., Karabuga B., Kaptan E., Aypak A., et al.

Future Virology , cilt.16, sa.5, ss.353-367, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

115. Disease characteristics of psoriatic arthritis patients may differ according to age at psoriasis onset: cross-sectional data from the Psoriatic Arthritis-International Database

Bilgin E., Aydin S. Z., Tinazzi I., Bayindir O., Kimyon G., Ozisler C., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.39, sa.3, ss.532-536, 2021 (SCI-Expanded, Scopus)

116. QuantiFERON®-TB Gold In-Tube test can be used for screening latent tuberculosis before biological treatment in a Bacille Calmette-Guérin (BCG)-vaccinated country: the HUR-BIO single-center real-life results

Seyhoglu E., UYAROĞLU O. A., Erden A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.

Clinical Rheumatology , cilt.40, sa.5, ss.2027-2035, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

117. COVID-19 outcomes in patients with familial Mediterranean fever: a retrospective cohort study

Güven S. C., Erden A., Karakaş Ö., Armağan B., Usul E., Omma A., et al.

Rheumatology International , cilt.41, sa.4, ss.715-719, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

118. PsART-ID inception cohort: Clinical characteristics, treatment choices and outcomes of patients with psoriatic arthritis

Ayan G., Aydin S. Z., Kimyon G., Ozisler C., Tinazzi I., Dogru A., et al.

Rheumatology (Bulgaria) , cilt.60, sa.4, ss.1755-1762, 2021 (Scopus)

119. Evaluation of 17 patients with COVID-19 pneumonia treated with anakinra according to HScore, SOFA, MuLBSTA, and Brescia-COVID respiratory severity scale (BCRSS) scoring systems

Erden A., Ozdemir B., Karakas O., Mutlu N. M., İZDEŞ S., Kalem A. K., et al.

Journal of Medical Virology , cilt.93, sa.3, ss.1532-1537, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

120. Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes

Monti S., Klersy C., Montecucco C., Caporali R., Watts R., Achilleos K., et al.

Rheumatology (United Kingdom) , cilt.60, sa.2, ss.617-628, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

121. Imaging modalities used in diagnosis and follow-up of patients with Takayasu’s arteritis

Keleşoğlu Dinçer A. B., KILIÇ L., Erden A., KALYONCU U., HAZIROLAN T., KİRAZ S., et al.

Turkish Journal of Medical Sciences , cilt.51, sa.1, ss.224-230, 2021 (SCI-Expanded, Scopus, TRDizin)

122. Convalescent Plasma Reduces Endogenous Antibody Response in COVID-19: A Retrospective Cross-Sectional Study Konvalesan Plazma COVID-19’da Endojen Antikor Yanıtını Azaltır: Retrospektif Kesitsel Bir Çalışma

Omma A., Erden A., Güven S. C., Ateş İ., KÜÇÜKŞAHİN O.

Turkish Journal of Hematology , cilt.38, sa.4, ss.321-324, 2021 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

123. Can Anakinra and corticosteroid treatment be an effective option in pregnant women with severe Covid-19?

Karakaş Ö., Erden A., Ünlü S., Erol S. A., Goncu Ayhan Ş., Özdemir B., et al.

Women and Health , cilt.61, sa.9, ss.872-879, 2021 (SSCI, Scopus)

124. Which hematological markers have predictive value as early indicators of severe COVID-19 cases in the emergency department?

Şan I., Gemcioğlu E., Davutoğlu M., Çatalbaş R., Karabuğa B., Kaptan E., et al.

Turkish Journal of Medical Sciences , cilt.51, sa.6, ss.2810-2821, 2021 (SCI-Expanded, Scopus, TRDizin)

125. Evaluation of inflammatory rheumatic diseases from an emergency medicine perspective

San I., Erden A., Gemcioglu E., KÜÇÜKŞAHİN O.

International Journal of Rheumatic Diseases , cilt.23, sa.12, ss.1670-1675, 2020 (SCI-Expanded)

126. False positivity of rose bengal test in patients with covid-19: Case series, uncontrolled longitudinal study

Gemcioglu E., Erden A., Karabuga B., Davutoglu M., Ates I., KÜÇÜKŞAHİN O., et al.

Sao Paulo Medical Journal , cilt.138, sa.6, ss.561-562, 2020 (SCI-Expanded)

127. Acute Ischemic Stroke in a Lupus Anticoagulant-Positive Woman With COVID-19.

Gemcioglu E., Erden A., Davutoglu M., Karabuga B., Kucuksahin O.

Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases , cilt.26, sa.6, ss.236-237, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

128. Pregnancy outcomes in partners of male ankylosing spondylitis patients treated with anti-tumour necrosis factor-α biologics: real-life results from a single-centre cross-sectional study

UYAROĞLU O. A., Seyhoglu E., Erden A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., et al.

Rheumatology International , cilt.40, sa.9, ss.1501-1507, 2020 (SCI-Expanded)

129. Current Smoking is Increased in Axial Psoriatic Arthritis and Radiographic Sacroiliitis

Solmaz D., Kalyoncu U., Tinazzi I., Bakirci S., Bayindir O., Dogru A., et al.

Journal of Rheumatology , cilt.47, sa.9, ss.1354-1358, 2020 (SCI-Expanded)

130. Neonatal Lupus Eritematozusa Bağlı Hematolojik, Hepatik, Nörolojik Ve Akciğer Tutulumunun Gözden Geçirilmesi: Hasta Bazlı Sistematik Litearatür Taraması

ERDEN A., BİLGİN E., ARMAĞAN B., SARI A., CEYLAN S., ŞENER Y. Z., et al.

Ankara Eğitim ve Araştırma Hastanesi Tıp Dergisi , cilt.53, sa.2, ss.120-124, 2020 (Hakemli Dergi)

131. The evaluation of rheumatoid arthritis patients with knee and hip prosthesis: HURBIO biological registry

ARMAĞAN B., ERDAT E. C., ERDEN A., SARI A., KALYONCU U., KİRAZ S., et al.

Ulusal Romatoloji Dergisi , cilt.12, sa.2, ss.39-44, 2020 (Hakemli Dergi)

132. Are type 1 interferons treatment in Multiple Sclerosis as a potential therapy against COVID-19?

Gemcioglu E., Davutoglu M., Ozdemir E. E., Erden A.

Multiple Sclerosis and Related Disorders , cilt.42, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

133. Psoriasis Symptom Inventory (PSI) as a patient-reported outcome in mild psoriasis: Real life data from a large psoriatic arthritis registry

AYDIN S. Z., KİMYON G., ÖZİŞLER C., TARHAN E. F., kasapoğlu günal e., KÜÇÜK A., et al.

EUROPEAN JOURNAL OF RHEUMATOLOGY , cilt.7, sa.2, ss.64-67, 2020 (ESCI)

134. Anti-interleukin-6 (Tocilizumab) therapy in takayasu’s arteritis: A real life experience

KILIÇ L., KARADAĞ Ö., Erden A., Sari A., Armağan B., Yardimci G. K., et al.

Turkish Journal of Medical Sciences , cilt.50, sa.1, ss.31-36, 2020 (SCI-Expanded)

135. A case of inappropriate antidiuretic hormone secretion syndrome associated with COVID-19 pneumonia

Gemcioglu E., Karabuga B., Ercan A., Erden A.

Acta Endocrinologica , cilt.16, sa.1, ss.110-111, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

136. A monogenic disease with a variety of phenotypes: Deficiency of adenosine deaminase 2

ÖZEN S., BATU AKAL E. D., Taşkiran E. Z., ÖZKARA H. A., Ünal Ş., Güleray N., et al.

Journal of Rheumatology , cilt.47, sa.1, ss.117-125, 2020 (SCI-Expanded, Scopus)

137. Geoepidemiology and clinical characteristics of neonatal lupus erythematosus: A systematic literature review of individual patients’ data

Erden A., Fanouriakis A., Kılıç L., Sari A., Armağan B., Bilgin E., et al.

Turkish Journal of Medical Sciences , cilt.50, sa.2, ss.281-290, 2020 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

138. Impact of Having Family History of Psoriasis or Psoriatic Arthritis on Psoriatic Disease

Solmaz D., Bakirci S., Kimyon G., Gunal E. K., DOĞRU A., Bayindir O., et al.

ARTHRITIS CARE & RESEARCH , cilt.72, sa.1, ss.63-68, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

139. The recommendations of Turkish Society for Rheumatology for pregnancy management in rheumatic diseases and the use of antirheumatic drugs during pregnancy

APRAŞ BİLGEN Ş. Ş., KILIÇ L., ERDEN A., ÖZBALKAN AŞLAR Z., BES C., KARABULUT G., et al.

Ulusal Romatoloji Dergisi , cilt.11, sa.2, ss.91-104, 2019 (Hakemli Dergi)

140. The role of micro and macrovascular disease in the etiology of left ventricular systolic dysfunction in systemic sclerosis

SARI A., ŞENER Y. Z., ARMAĞAN B., ERDEN A., KILIÇ L., KARADAĞ Ö., et al.

Ulusal Romatoloji Dergisi , cilt.11, sa.2, ss.105-109, 2019 (Hakemli Dergi)

141. Two cases of glutaric aciduria type II: how to differentiate from inflammatory myopathies?

Koca M., Erden A., Armagan B., Sari A., Yildiz F., Ozdamar S., et al.

Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine , cilt.74, sa.6, ss.451-455, 2019 (SCI-Expanded)

142. Serum neopterin and ischemia modified albumin levels are associated with the disease activity of adult immunoglobulin A vasculitis (Henoch-Schönlein purpura)

Omma A., Colak S., Can Sandikci S., Yucel C., Erden A., Sertoglu E., et al.

International Journal of Rheumatic Diseases , cilt.22, sa.10, ss.1920-1925, 2019 (SCI-Expanded)

143. Do ANCA-associated vasculitides and IgG4-related disease really overlap or not?

Erden A., Bolek E. C., Yardimci K. G., KILIÇ L., Bilgen S. A., KARADAĞ Ö.

International Journal of Rheumatic Diseases , cilt.22, sa.10, ss.1926-1932, 2019 (SCI-Expanded, Scopus)

144. What are the main barriers to achieve minimal disease activity in psoriatic arthritis in real life?

Bakirci S., Solmaz D., Al Osaimi N., Dalkilic E., Can M., Erden A., et al.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY , cilt.37, sa.5, ss.808-812, 2019 (SCI-Expanded, Scopus)

145. Increased incidence of spondyloarthropathies in patients with Takayasu arteritis: a systematic clinical survey

Esen S. G., Armagan B., Atas N., UÇAR M., Varan O., Erden A., et al.

JOINT BONE SPINE , cilt.86, sa.4, ss.497-501, 2019 (SCI-Expanded, Scopus)

146. Wide heterogeneity in treatment protocols and inappropiate use of prednisolone for anti-Ro/La associated-congenital heart block: a systematic review of 492 cases

ERDEN A., KILIÇ L., SARI A., ARMAĞAN B., BİLGİN E., CEYLAN S., et al.

Ulusal Romatoloji Dergisi , cilt.11, sa.1, ss.10-15, 2019 (Hakemli Dergi)

147. Proposal for a simple algorithm to differentiate adult-onset Still’s disease with other fever of unknown origin causes: a longitudinal prospective study

BİLGİN E., HAYRAN K. M., Erden A., Armağan B., Sarı A., KILIÇ L., et al.

Clinical Rheumatology , cilt.38, sa.6, ss.1699-1706, 2019 (SCI-Expanded)

148. Successful Treatment of Amyloid A-Type Amyloidosis Due to Behçet Disease With Tocilizumab

Ilbay A., Erden A., Sari A., Armagan B., Aktas B. Y., Bolek E. C., et al.

Journal of Clinical Rheumatology , cilt.25, sa.4, 2019 (SCI-Expanded)

149. Switching between biological DMARDs and associated reasons in rheumatoid arthritis and spondyloarthritis treatments: TReasure study-real life data

KALYONCU U., ERTENLİ A. İ., KÜÇÜKŞAHİN O., DALKILIÇ H. E., ERDEN A., BES C., et al.

Ulusal Romatoloji Dergisi , cilt.11, sa.1, ss.1-9, 2019 (Hakemli Dergi)

150. Deficiency of adenosine deaminase 2; special focus on central nervous system imaging

Bulut E., Erden A., KARADAĞ Ö., Oguz K. K., ÖZEN S.

Journal of Neuroradiology , cilt.46, sa.3, ss.193-198, 2019 (SCI-Expanded)

151. Change in PsAID-12 scores in patients continuing or discontinuing anti-TNF treatments in psoriatic arthritis: results from the HUR-BIO biologic registry

KALYONCU U., KİRAZ S., Bilgen S. A., KARADAĞ Ö., AKDOĞAN A., KILIÇ L., et al.

Clinical Rheumatology , cilt.38, sa.4, ss.1187-1192, 2019 (SCI-Expanded)

152. Correction to: Proposal for a simple algorithm to differentiate adult-onset Still's disease with other fever of unknown origin causes: a longitudinal prospective study.

Bilgin E., Hayran M., Erden A., Armağan B., Sarı A., Kılıç L., et al.

Clinical rheumatology , cilt.38, sa.4, ss.1193-1194, 2019 (SCI-Expanded)

153. Polyarteritis nodosa: lessons from 25 years of experience

Sönmez H. E., Armağan B., Ayan G., BARUT K., BATU AKAL E. D., Erden A., et al.

Clinical and experimental rheumatology , cilt.37, sa.2, ss.52-56, 2019 (SCI-Expanded) Sürdürülebilir Kalkınma

154. Frequency of Behçet’s disease among a group of visually impaired adults

UYAROĞLU O. A., Seyhoglu E., Erden A., Vahabov C., Babaoglu H., Armagan B., et al.

Irish Journal of Medical Science , cilt.188, sa.1, ss.333-336, 2019 (SCI-Expanded)

155. Abnormal retinal microvasculature found in active rheumatoid arthritis: A different perspective of microvascular health

Babaoğlu H., Baytaroğlu A., Torğutalp M., Erden A., KADAYIFÇILAR S., KALYONCU U.

Turkish Journal of Medical Sciences , cilt.49, sa.1, ss.20-26, 2019 (SCI-Expanded, Scopus, TRDizin)

156. Capillaroscopic findings in turkish takayasu arteritis patients

AKDOĞAN A., Erden A., Firat Şentürk E., KILIÇ L., Sari A., Armağan B., et al.

Turkish Journal of Medical Sciences , cilt.49, sa.5, ss.1303-1307, 2019 (SCI-Expanded, Scopus, TRDizin)

157. Behçet’s disease; A rare refractory patient with vena cava superior syndrome treated with infliximab: a case report and review of the literature

Uyaroglu O. A., Erden A., KILIÇ L., PEYNİRCİOĞLU B., KARADAĞ Ö., KALYONCU U.

Acta Clinica Belgica: International Journal of Clinical and Laboratory Medicine , cilt.74, sa.5, ss.364-369, 2019 (SCI-Expanded)

158. Low disease activity—irrespective of serologic status at baseline—associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study

Fanouriakis A., Adamichou C., Koutsoviti S., Panopoulos S., Staveri C., Klagou A., et al.

Seminars in Arthritis and Rheumatism , cilt.48, sa.3, ss.467-474, 2018 (SCI-Expanded)

159. Rituximab therapy in renal amyloidosis secondary to rheumatoid arthritis

KILIÇ L., Erden A., Sener Y. Z., Armagan B., Sari A., KALYONCU U., et al.

Biomolecules , cilt.8, sa.4, 2018 (SCI-Expanded)

160. Axial psoriatic arthritis: the impact of underdiagnosed disease on outcomes in real life

Aydin S. Z., KÜÇÜKŞAHİN O., KILIÇ L., DOĞRU A., Bayindir O., Ozisler C., et al.

Clinical Rheumatology , cilt.37, sa.12, ss.3443-3448, 2018 (SCI-Expanded)

161. Comparing immunoglobulin A vasculitis (Henoch–Schönlein purpura) in children and adults: a single-centre study from Turkey

BATU AKAL E. D., Sarı A., Erden A., SÖNMEZ H., Armağan B., KALYONCU U., et al.

Scandinavian Journal of Rheumatology , cilt.47, sa.6, ss.481-486, 2018 (SCI-Expanded)

162. Is the PET/CT first choice for differential diagnosis of fever of FUO/IUO?

Armagan B., Erden A., Beydas O., Sari A., KILIÇ L., KALYONCU U.

Annals of the Rheumatic Diseases , cilt.77, sa.11, 2018 (SCI-Expanded)

163. Which definition should be used to determine colchicine resistance among patients with familial Mediterranean fever?

Erden A., BATU AKAL E. D., Sarı A., Sönmez H. E., Armagan B., Demir S., et al.

Clinical and experimental rheumatology , cilt.36, sa.6, ss.97-102, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

164. A retrospective study comparing the phenotype and outcomes of patients with polyarteritis nodosa between UK and Turkish cohorts

KARADAĞ Ö., Erden A., BİLGİNER Y., Gopaluni S., Sari A., Armagan B., et al.

Rheumatology International , cilt.38, sa.10, ss.1833-1840, 2018 (SCI-Expanded, Scopus)

165. In early arthritis patients, high HAQ at baseline and DAS28 at three months predict suboptimal outcomes at two years: A retrospective cohort study

Fanouriakis A., Papalopoulos I., Gergianaki I., Spyrou G., Erden A., Rapsomaniki P., et al.

Clinical and Experimental Rheumatology , cilt.36, sa.5, ss.806-813, 2018 (SCI-Expanded)

166. Pulmonary hypertension in Takayasu arteritis

Sari A., Sener Y. Z., Firat E., Armagan B., Erden A., Oksul M., et al.

International Journal of Rheumatic Diseases , cilt.21, sa.8, ss.1634-1639, 2018 (SCI-Expanded, Scopus)

167. A rare cause of proximal muscle weakness: immune necrotising myopathy

Can Guven D., Erden A., KILIÇ L., Ozdamar S. E., KARADAĞ Ö.

Scottish Medical Journal , cilt.63, sa.3, ss.82-86, 2018 (SCI-Expanded)

168. Evaluation of Vitamin B12 Deficiency and Associated Factors in Patients with Systemic Sclerosis

Tas Kilic D., AKDOĞAN A., KILIÇ L., Sari A., Erden A., Armagan B., et al.

Journal of Clinical Rheumatology , cilt.24, sa.5, ss.250-254, 2018 (SCI-Expanded, Scopus)

169. Nationwide Experience With Off-Label Use of Interleukin-1 Targeting Treatment in Familial Mediterranean Fever Patients

AKAR S., Cetin P., KALYONCU U., KARADAĞ Ö., Sari I., Cinar M., et al.

ARTHRITIS CARE & RESEARCH , cilt.70, sa.7, ss.1090-1094, 2018 (SCI-Expanded, Scopus)

170. Familial Mediterranean Fever: New Insights Into Cancer Immunoprevention? Comment on the Article by Brenner et al

BİLGİN E., Erden A., DİZDAR Ö.

Arthritis and Rheumatology , cilt.70, sa.7, ss.1167, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

171. Assessment of subclinical atherosclerosis in psoriatic arthritis patients without clinically overt cardiovascular disease or traditional atherosclerosis risk factors

APRAŞ BİLGEN Ş. Ş., KALYONCU U., ERDEN A., CANPOLAT U., KILIÇ L., KARADAĞ Ö., et al.

TURK KARDIYOLOJI DERNEGI ARSIVI , cilt.46, sa.5, ss.358-365, 2018 (Scopus, TRDizin) Sürdürülebilir Kalkınma

172. Some concerns and improvements from Turkey

ÇINAR O. E., Erden A., Sari A., Armagan B., KILIÇ L.

Annals of the Rheumatic Diseases , cilt.77, sa.6, 2018 (SCI-Expanded)

173. Blood group 'A' may have a possible modifier effect on familial Mediterranean fever and blood group '0' may be associated with colchicine resistance

Erden A., BATU AKAL E. D., Armagan B., Sönmez H. E., Sari A., Demir S., et al.

Biomarkers in Medicine , cilt.12, sa.6, ss.565-572, 2018 (SCI-Expanded)

174. Remission of relapsing polychondritis after successful treatment of myelodysplastic syndrome with azacitidine: a case and review of the literature

ERDEN A., BİLGİN E., KILIÇ L., SARI A., ARMAĞAN B., BÜYÜKAŞIK Y., et al.

DRUG METABOLISM AND PERSONALIZED THERAPY , cilt.33, sa.2, ss.105-108, 2018 (Scopus)

175. Aspergillus Pneumonia in a Patient With Adult-Onset Still Disease Successfully Treated With Anakinra

BİLGİN E., Erden A., KILIÇ L., Sari A., Armagan B., KALYONCU U., et al.

Journal of Clinical Rheumatology , cilt.24, sa.3, ss.156-158, 2018 (SCI-Expanded)

176. Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidity

Armagan B., Sari A., Erden A., KILIÇ L., Erdat E. C., Kilickap S., et al.

Medicine (United States) , cilt.97, sa.13, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

177. Pulmonary aspergillosis after treatment with infliximab in Still’s disease and a literature review of Still’s disease and pulmonary aspergillosis

ŞEYHOĞLU E., ERDEN A., KILIÇ L., KARADAĞ Ö., ARIKAN AKDAĞLI S., AKDOĞAN A., et al.

EUROPEAN JOURNAL OF RHEUMATOLOGY , cilt.5, sa.1, ss.75-78, 2018 (Hakemli Dergi)

178. Clinical and laboratory features of metformin intoxication in suicidal patients attending an intensive care unit

Cetinkaya A., Avci D., Erden A., Akca O., Ozer O., Kalan U., et al.

Nigerian Journal of Clinical Practice , cilt.21, sa.2, ss.143-148, 2018 (SCI-Expanded) Sürdürülebilir Kalkınma

179. Increased psoriasis frequency in patients with familial Mediterranean fever

Erden A., BATU AKAL E. D., Seyhoğlu E., Sari A., Sönmez H. E., Armagan B., et al.

Upsala Journal of Medical Sciences , cilt.123, sa.1, ss.57-61, 2018 (SCI-Expanded)

180. Rituximab experience in patients with long-standing systemic sclerosis-associated interstitial lung disease: A series of 14 patients

Sari A., Guven D., Armagan B., Erden A., KALYONCU U., KARADAĞ Ö., et al.

Journal of Clinical Rheumatology , cilt.23, sa.8, ss.411-415, 2017 (SCI-Expanded, Scopus)

181. IgG4-related sclerosing disease with mesenteric and retroperitoneal involvement

Yetkin D. I., ONUR M. R., KARADAĞ Ö., ERDEN A., AKPINAR E., KÖSEMEHMETOĞLU K.

EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE , cilt.48, sa.4, ss.767-769, 2017 (Scopus)

182. Retention Rate of Etanercept in Patients with Rheumatoid Arthritis Is Better Than That of Monoclonal Antibody

ERDEN A., KILIÇ L., KARADAĞ Ö., KİRAZ S., KILIÇKAP S., AKDOĞAN A., et al.

Acta Medica , cilt.48, sa.3, ss.11-17, 2017 (Hakemli Dergi)

183. An Independent Risk Factor for Diabetic Retinopathy: Uric Acid

avcı d., KARAHAN S., çetinkaya a., karagöz h., esmeray k., buğday i., et al.

Journal of Global Diabetes Clinical Metabolism , cilt.2, sa.4-022, ss.1-5, 2017 (Hakemli Dergi) Sürdürülebilir Kalkınma

184. Rare occupational cause of nasal septum perforation: Nickel exposure

Bolek E. Ç., Erden A., Kulekci C., KALYONCU U., KARADAĞ Ö.

International journal of occupational medicine and environmental health , cilt.30, sa.6, ss.963-967, 2017 (SCI-Expanded) Sürdürülebilir Kalkınma

185. Evaluation of psoriasis patients with a rheumatologic questionnaire efficiently aids in early detection of psoriatic arthritis

DOĞAN GÜNAYDIN S., ATAKAN Z. N., KOÇ YILDIRIM S., KALYONCU U., ERDEN A.

DERI HASTALIKLARI VE FRENGI ARSIVI , cilt.51, sa.3, ss.88-91, 2017 (Hakemli Dergi) Sürdürülebilir Kalkınma

186. Comparing polyarteritis nodosa in children and adults: a single center study

Erden A., BATU AKAL E. D., SÖNMEZ H., Sarı A., Armagan B., Arıcı Z. S., et al.

International Journal of Rheumatic Diseases , cilt.20, sa.8, ss.1016-1022, 2017 (SCI-Expanded)

187. Romatizmalı hastalar için bir yaşam kalitesi ölçeğinin geliştirilmesi: madde havuzunun oluşturulması

ÜNAL E., ARIN G., KARACA N. B., KİRAZ S., AKDOĞAN A., KALYONCU U., et al.

Journal of Exercise Therapy and Rehabilitation , cilt.4, sa.2, ss.67-75, 2017 (Hakemli Dergi)

188. Revision of the demographic and clinical data of patients with ulcerative colitis in Turkey

karagöz h., ERDEN A., karaman h., KARAMAN A.

Medicinski Glasnik , cilt.14, sa.2, ss.224-228, 2017 (Scopus)

189. The values of mean platelet volume and the mean platelet volume/platelet ratio for predicting deep venous thrombosis in Behçet's disease

Erden F., Karagoz H., Avci A., Avci D., Cetinkaya A., Erden A.

LaboratoriumsMedizin , cilt.41, sa.3, ss.153-157, 2017 (SCI-Expanded)

190. The Psoriatic Arthritis Registry of Turkey: Results of a multicentre registry on 1081 patients

KALYONCU U., Bayindir Ö., Öksüz M. F., DOĞRU A., Kimyon G., Tarhan E. F., et al.

Rheumatology (United Kingdom) , cilt.56, sa.2, ss.279-286, 2017 (SCI-Expanded)

191. Assessment of the HScore for reactive haemophagocytic syndrome in patients with rheumatic diseases

BATU AKAL E. D., Erden A., Seyhoğlu E., KILIÇ L., BÜYÜKAŞIK Y., KARADAĞ Ö., et al.

Scandinavian Journal of Rheumatology , cilt.46, sa.1, ss.44-48, 2017 (SCI-Expanded, Scopus)

192. The clinical features and outcomes of Turkish patients with IgG4-related disease: A single-center experience

KARADAĞ Ö., Erden A., AYHAN E. A., Bölek E. Ç., KALYONCU U., Armağan B., et al.

Turkish Journal of Medical Sciences , cilt.47, sa.5, ss.1307-1314, 2017 (SCI-Expanded)

193. The role of blood groups in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

Karagoz H., Erden A., Ozer O., Cetinkaya A., Avci D., Gencer V., et al.

Acta Medica Mediterranea , cilt.33, sa.2, ss.205-210, 2017 (SCI-Expanded)

194. Which one is best? Platelet/lymphocyte ratio, neutrophil/lymphocyte ratio or both in determining deep venous thrombosis in behcet’s disease?

Erden F., Karagoz H., Avci A., Avci D., Cetinkaya A., BAHADIR Ş., et al.

Biomedical Research (India) , cilt.28, sa.12, ss.5304-5309, 2017 (Scopus)

195. Orbital Involvement and Ocular Surface Changes in IgG4-Related Systemic Disease

KOCABEYOĞLU S., KARADAĞ Ö., Mocan M. C., Erden A., Irkec M.

Cornea , cilt.35, sa.11, ss.1449-1453, 2016 (SCI-Expanded, Scopus)

196. The reporting of patient-reported outcomes in studies of patients with rheumatoid arthritis: A systematic review of 250 articles

KILIÇ L., Erden A., Bingham C. O., Gossec L., KALYONCU U.

Journal of Rheumatology , cilt.43, sa.7, ss.1300-1305, 2016 (SCI-Expanded)

197. Are the blood groups of women with preeclampsia a risk factor for the development of hypertension postpartum?

Avci D., Karagoz H., Ozer O., Esmeray K., Bulut K., Aykas F., et al.

Therapeutics and Clinical Risk Management , cilt.12, ss.617-622, 2016 (SCI-Expanded)

198. Effect of anterior uveitis in Behçet’xxs disease onneutrophil to lymphocyte ratio

avcı a., avcı d., ÇINAR S. L., çetinkaya a., Karahan S., ERDEN A., et al.

INTERNATIONAL EYE SCIENCE , cilt.16, sa.4, ss.607-609, 2016 (Scopus)

199. Acute Pancreatitis Caused By Mushroom Poisoning: A Report of Two Cases

karahan s., ERDEN A., çetinkaya a., avcı d., ortaköylüoğlu a. i., karagoz h., et al.

Journal of Investigative Medicine High Impact Case Reports , cilt.4, sa.1, ss.1-3, 2016 (Scopus)

200. The role of blood groups in the development of diabetes mellitus after gestational diabetes mellitus

Karagoz H., Erden A., Ozer O., Esmeray K., Cetinkaya A., Avci D., et al.

Therapeutics and Clinical Risk Management , cilt.11, ss.1613-1617, 2015 (SCI-Expanded) Sürdürülebilir Kalkınma

201. Golimumab using in ankylosing spondylitis patients: HUR-BIO/Spondyloarthritis real life experience

ERDEN A., KILIÇ L., KARADAĞ Ö., AKDOĞAN A., APRAŞ BİLGEN Ş. Ş., KİRAZ S., et al.

RAED Dergisi , cilt.7, sa.1, ss.6-9, 2015 (Hakemli Dergi)

202. Persistence of cardiovascular risk factors in women with previous preeclampsia: A long-term follow-up study

Aykas F., Solak Y., Erden A., Bulut K., Dogan S., Sarli B., et al.

Journal of Investigative Medicine , cilt.63, sa.4, ss.641-645, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

203. Reversible slurred speech related to capecitabine and lapatinib combination in patients with breast cancer

Mutlu H., Büyükçelik A., Akça Z., Erden A.

Journal of Oncology Pharmacy Practice , cilt.21, sa.1, ss.72-73, 2015 (Scopus) Sürdürülebilir Kalkınma

204. Non alcoholic steatohepatitis is associated with subclinical impairment in left ventricular function measured by speckle tracking echocardiography

Baktır A. O., Şarlı B., Altekin R. E., Karaman A., Arınç H., Sağlam H., et al.

ANADOLU KARDIYOLOJI DERGISI , cilt.15, sa.2, ss.137-142, 2015 (SCI-Expanded)

205. Spondiloartritlere Özel Hastalıklar:Psöriyazis, İnflamatuar Barsak Hastalığı, Üveit

ERDEN A., ERTENLİ A. İ.

Turkiye Klinikleri J Rheumatol , cilt.8, sa.1, ss.44-50, 2015 (Hakemli Dergi)

206. Clinicopathologic case discussion: systemic onset juvenil idiopathic arthritis and acut-subacute heart failure

KILIÇ L., TORĞUTALP M., ERDEN A., KALYONCU U.

RAED Dergisi , cilt.6, sa.2, ss.67-72, 2014 (Hakemli Dergi)

207. Is hypertriglyceridemia a prognostic factor in sepsis?

Cetinkaya A., Erden A., Avci D., Karagoz H., Karahan S., Basak M., et al.

Therapeutics and Clinical Risk Management , cilt.10, sa.1, ss.147-150, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

208. Disseminated intravascular coagulopathy caused by Kikuchi-Fujimoto disease resulting in death: first case report in Turkey

USLU YURTERİ E., gürbüz s., ERDEN A., AYKAŞ F., karagöz h., Karahan S., et al.

INTERNATIONAL MEDICAL CASE REPORTS JOURNAL , cilt.7, sa.NULL, ss.19-22, 2014 (Scopus)

209. Uric acid as a potential mediator of cardiovascular morbidity in obstructive sleep apnea syndrome

Kanbay A., Inonu H., Solak Y., Erden A., Uslu E., Yuksel S. A., et al.

European Journal of Internal Medicine , cilt.25, sa.5, ss.471-476, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

210. The Relationship between ABO Blood Group and Glioblastoma Multiforme

AKÇA Z., MUTLU H., ERDEN A., BÜYÜKÇELİK A., SEZER YAMAN E., İNAL A.

Medicine Science , cilt.3, sa.4, ss.1639-1647, 2014 (Hakemli Dergi)

211. Lack of sunlight exposure influence on primary glioblastoma survival

Mutlu H., Akca Z., Erden A., Aslan T., Ucar K., Kaplan B., et al.

Asian Pacific Journal of Cancer Prevention , cilt.15, sa.10, ss.4165-4168, 2014 (SCI-Expanded)

212. Survival analysis of biliary tract cancer cases in Turkey

Akca Z., Mutlu H., Erden A., Buyukcelik A., Cihan Y. B., Goksu S. S., et al.

Asian Pacific Journal of Cancer Prevention , cilt.15, sa.15, ss.6025-6027, 2014 (SCI-Expanded)

213. Diffüz İdiyopatik İskelet Hiperostozu

ERDEN A., KALYONCU U.

Turkiye Klinikleri J Rheumatol , cilt.7, sa.1, ss.5-10, 2014 (Hakemli Dergi)

214. Second-line gemcitabine-based chemotherapy regimens improve overall 3-year survival rate in patients with malignant pleural mesothelioma: A multicenter retrospective study

Mutlu H., Gündüz Ş., Karaca H., Büyükçelik A., Cihan Y. B., Erden A., et al.

Medical Oncology , cilt.31, sa.8, 2014 (SCI-Expanded)

215. QT Dispersion Which Predicts Cardiovascular Adverse Event Risk, Increases In Non Alcoholic Fatty Liver Disease

baktır a. o., ŞARLI B., KARAMAN A., ARINÇ H., SAĞLAM H., Karaman H., et al.

Abant Tıp Dergisi , cilt.3, sa.1, ss.33-37, 2014 (Hakemli Dergi)

216. Codeine-induced syndrome of inappropriate antidiuretic hormone: Case report

Karahan S., Karagöz H., Erden A., Avci D., Esmeray K.

Balkan Medical Journal , cilt.31, sa.1, ss.107-109, 2014 (SCI-Expanded)

217. Colchicine intoxication: A report of two suicide cases

Erden A., Karagoz H., Gümüscü H. H., Karahan S., Basak M., Aykas F., et al.

Therapeutics and Clinical Risk Management , cilt.9, sa.1, ss.505-509, 2013 (SCI-Expanded)

218. Acute liver failure caused by mushroom poisoning: a case report and review of the literature

ERDEN A., Esmeray K., karagöz h., Karahan S., GÜMÜŞÇÜ H. H., BAŞAK M., et al.

INTERNATIONAL MEDICAL CASE REPORTS JOURNAL , cilt.6, sa.NULL, ss.85-90, 2013 (Scopus)

219. A case of bismuth intoxication with irreversible renal damage

ERDEN A., Karahan S., BULUT K., BAŞAK M., ASLAN T., çetinkaya a., et al.

INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE , cilt.6, sa.NULL, ss.241-243, 2013 (Scopus)

220. Serum gamma glutamyl transferase and alanine transaminase concentrations predict endothelial dysfunction in patients with non-alcoholic steatohepatitis

Arinc H., Sarli B., Baktir A. O., Saglam H., Demirci E., Dogan Y., et al.

Upsala Journal of Medical Sciences , cilt.118, sa.4, ss.228-234, 2013 (SCI-Expanded)

221. GERIATRIC VERSUS NON GERIATRIC GROUPS IN POSTMENOPAUSAL BREAST CANCER PATIENTS LYMPHOVASCULAR INVASION IS SIGNIFICANTLY DIFFERENT

MUTLU H., akça z., ERDEN A., aslan t., benderli cihan y., büyükçelik a.

TURK GERIATRI DERGISI , cilt.16, sa.3, ss.305-308, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

222. Suicide commitment with metformin: Our experience with five cases

Avci D., Çetinkaya A., Karahan S., Oǧuzhan N., Karagöz H., Başak M., et al.

Renal Failure , cilt.35, sa.6, ss.863-865, 2013 (SCI-Expanded)

223. Alteration in mean platelet volume and platicrit values in patients with cancer that developed thrombosis

Mutlu H., Artiş T. A., Erden A., Akca Z.

Clinical and Applied Thrombosis/Hemostasis , cilt.19, sa.3, ss.331-333, 2013 (SCI-Expanded) Sürdürülebilir Kalkınma

224. Adjuvan Kemoradyoterapi Alan Meme Kanserli Hastalarda Tümör Lokalizasyonunun Akciğer Toksisitesine Etkisi

MUTLU H., AKÇA Z., BERK V., ERDEN A., ASLAN T., UĞUR H.

KONURALP TIP DERGISI , cilt.5, sa.2, ss.33-35, 2013 (Hakemli Dergi)

225. Lithium intoxication and nephrogenic diabetes insipidus: a case report and review of literature

ERDEN A., karagöz h., BAŞAK M., Karahan S., çetinkaya a., avcı d., et al.

INTERNATIONAL JOURNAL OF GENERAL MEDICINE , cilt.6, sa.NULL, ss.535-539, 2013 (Scopus)

226. The Relationship Among Mean Platelet Volume,Platelet Count, Risk Factors and ThromboembolicEvent in Patients with Cancer

MUTLU H., AKÇA Z., BENDERLİ CİHAN Y., ERDEN A., ASLAN T., UĞUR H., et al.

Yeni Tıp Dergisi , cilt.30, sa.2, ss.89-92, 2013 (Hakemli Dergi)

227. Gastrointestinal kanama ile başvuran erişkin başlangıçlı Henoch-Schönlein vasküliti ve ankilozan spondilitli bir olgu

BAŞAK M., ERDEN A., BULUT K., AYKAŞ F., karaman h., KARAMAN A.

Endoskopi , cilt.21, sa.1, ss.19-21, 2013 (Hakemli Dergi)

228. Blue lunula related with hydroxyurea Hidroksiüre i̇lişkili mavi lunula

ÜSKÜDAR TEKE H., Erden A.

Turkish Journal of Hematology , cilt.30, sa.1, ss.100-101, 2013 (SCI-Expanded)

229. Malignant peritoneal mesothelioma: Two cases andliterature review

OĞUZ A., KARAMAN A., AYKAŞ F., ERDEN A.

International Journal of Medicineand Medical Sciences , cilt.5, sa.3, ss.95-96, 2013 (Hakemli Dergi)

230. Alteration of Complementary and Alternative Medicine Usage in Patients With Cancer in Turkey

MUTLU H., AKÇA Z., BENDERLİ CİHAN Y., ASLAN T., ERDEN A., BÜYÜKÇELİK A.

Medicine Science , cilt.2, sa.3, ss.757-763, 2013 (Hakemli Dergi)

231. Is season a prognostic factor in breast cancer?

Mutlu H., Akca Z., Cihan Y. B., Kurnaz F., Aslan T., Erden A., et al.

Asian Pacific Journal of Cancer Prevention , cilt.14, sa.2, ss.743-746, 2013 (SCI-Expanded)

232. Should FISH Test be Performed to all Patients With Breast Cancer?

MUTLU H., KARACA H., AKÇA Z., ALTUNER TORUN Y., ERDEN A., ASLAN T., et al.

Medicine Science , cilt.2, sa.2, ss.539-547, 2013 (Hakemli Dergi)

233. The Optimal Chemotherapy Timing in Patients with Inoperable Locally Advanced Non Small Cell Lung Cancer

MUTLU H., BÜYÜKÇELİK A., ASLAN T., ERDEN A., AKÇA Z.

MEDICINSKI ARHIV , cilt.67, sa.2, ss.104-106, 2013 (Scopus) Sürdürülebilir Kalkınma

234. Is sunlight a predisposing factor for triple negative breast cancer in Turkey?

Mutlu H., Büyükçelik A., Çolak T., Özdoǧan M., Erden A., Aslan T., et al.

Asian Pacific Journal of Cancer Prevention , cilt.14, sa.2, ss.801-803, 2013 (SCI-Expanded)

235. Staging with PET-CT in patients with locally advanced non small cell lung cancer is superior to conventional staging methods in terms of survival

Mutlu H., Buyukcelik A., Erden A., Aslan T., Akca Z., Kaya E., et al.

Asian Pacific Journal of Cancer Prevention , cilt.14, sa.6, ss.3743-3746, 2013 (SCI-Expanded)

236. An Acute Edematous Pancreatitis Case Developed On The Basis Of Hypertriglyceridemia

ASLAN T., ERDEN A., karagöz h., Karahan S., AYKAŞ F., USLU YURTERİ E., et al.

MEDICINSKI ARHIV , cilt.67, sa.4, ss.295-296, 2013 (Scopus)

237. Relationship between colonic polyp type and the neutrophil/lymphocyte ratio as a biomarker

Karaman H., Karaman A., Erden A., Poyrazoglu O. K., KARAKÜKCÜ Ç., Tasdemir A.

Asian Pacific Journal of Cancer Prevention , cilt.14, sa.5, ss.3159-3161, 2013 (SCI-Expanded)

238. Secondline chemotherapy versus best supportive care in patient with malignant pleural mesothelioma: A retrospective study

Mutlu H., Buyukcelik A., Karaca H., Aksahin A., Berk V., Aslan T., et al.

Asian Pacific Journal of Cancer Prevention , cilt.14, sa.6, ss.3887-3889, 2013 (SCI-Expanded)

239. Does sunlight exposure improve survival in patients with non-small cell lung cancer?

Mutlu H., Buyukcelik A., Aksahin A., Kibar M., Cihan Y. B., Kaya E., et al.

Asian Pacific Journal of Cancer Prevention , cilt.14, sa.11, ss.6301-6304, 2013 (SCI-Expanded)

240. THE NEUTROPHIL/LYMPHOCYTE RATIO MAY BE AN INDICATOR OF ADVANCED DISEASE IN PATIENTS WITH NON SMALL CELL LUNG CANCER

MUTLU H., ERDEN A., ASLAN T., AKÇA Z., OĞUZ A., BÜYÜKÇELİK A.

ADVANCE LABORATORY MEDICINE INTERNATIONAL , cilt.2, sa.4, ss.142-148, 2012 (Hakemli Dergi)

241. OSTEOPOROSIS ASSOCIATED WITH AROMATASE INHIBITORS ISDIFFERENT FROM POST-MENOPAUSAL OSTEOPOROSIS

MUTLU H., ASLAN T., yılmaz silov g., ERDEN A., BENDERLİ CİHAN Y., AKÇA Z., et al.

ADVANCE LABORATORY MEDICINE INTERNATIONAL , cilt.3, sa.1, ss.1-5, 2012 (Hakemli Dergi)

242. Single-dose-dexketoprofen-induced acute kidney injury due to massive rhabdomyolysis

Sav T., Unal A., Erden A., Gunal A. I.

International Urology and Nephrology , cilt.44, sa.5, ss.1581-1583, 2012 (SCI-Expanded)

243. Treatment regimen with bevacizumab decreases mean platelet volume in patients with metastatic colon cancer

Mutlu H., Berk V., Karaca H., Erden A., Aslan T., Akca Z.

Clinical and Applied Thrombosis/Hemostasis , cilt.18, sa.5, ss.546-548, 2012 (SCI-Expanded)

244. Periton Tüberkülozu Olgusu

KARAMAN A., ERDEN A., Karaman H., USLU YURTERİ E., ÖZGÜL GÜMÜŞ Ü.

Ankara Medical Journal , cilt.12, sa.2, ss.103-105, 2012 (Hakemli Dergi)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 106

1. POS0857 REMARKING THE OSTEOPOROSIS IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS (AAV): DATA FROM EASTERN MEDITERRANEAN (TRVAS)

Demirci Yıldırım T., ERPEK KARAOVA E., ÖZDEMİR ULUSOY B., ÜNALDI E., SADİOĞLU ÇAĞDAŞ Ö., KARDAŞ R. C., et al.

EULAR 2024 |, Viyana, Avusturya, 08 Ekim 2024, ss.1069-1070, (Tam Metin Bildiri)

2. AB1017 SLE PATIENTS EXHIBIT WALL THICKENING IN MAJOR VEINS ACROSS THE BODY

KARADENİZ H., YILDIRIM D., İbrahimhanlı N., koç kanık h. n., VASİ İ., DURAN R., et al.

EULAR 2024 |, Viyana, Avusturya, 12 Haziran 2024, ss.1826-1827, (Tam Metin Bildiri)

3. AB1189 THE CIRCULATING LEVELS OF ENDOGENOUS EICOSAPENTAENOIC ACID AND DOCOSAHEXAENOIC ACID-DERIVED RESOLVINS ARE INCREASED IN SYSTEMIC SCLEROSIS: EVIDENCE FROM A SINGLE CENTRE COHORT

Avanoğlu Güler A., Çoşkun C., Karadeniz H., Gökgöz Acar S., Bilici R., Satış H., et al.

EULAR 2024 , Vienna, Avusturya, 12 Haziran 2024, cilt.83, ss.1930-1931, (Tam Metin Bildiri)

4. POS0218 VENOUS THROMBOEMBOLISM IN ANCA-ASSOCIATED VASCULITIS MIGHT BE ASSOCIATED WITH DISEASE ACTIVITY: RESULTS OF TR-VaS COHORT

KOCAAYAN H., Durak Ediboğlu E., Demirci Yıldırım T., ÖZDEMİR B., Öğüt T. S., FIRLATAN B., et al.

EULAR 2024 |, Viyana, Avusturya, 12 Haziran 2024, (Tam Metin Bildiri)

5. AB1327 VALIDATION OF THE 2022 ACR/EULAR CLASSIFICATION CRITERIA FOR LARGE-VESSEL VASCULITIS; CONFUSION OF CLASSIFICATION BETWEEN CERTAIN AGES REMAINS

ÖZDEMİR ULUSOY B., ERDEN A., GÜVEN S. C., ARMAĞAN B., KAYACAN ERDOĞAN E., AKYÜZ DAĞLI P., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.2012-2013, (Özet Bildiri)

6. AB0535 ALMOST TWO AND HALF PRECENTAGE OF RA PATIENTS HAD DIFFICULT TO TREAT (D2T): RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

AYAN G., KARABULUT E., SATIŞ H., ERDEN A., BİLGİN E., ARMAĞAN B., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.1545, (Özet Bildiri)

7. AB0641 DEMOGRAPHIC CHARACTERISTICS, COMORBIDITIES AND TREATMENT CHOICES OF EARLY AND LATE ONSET RA PATIENTS: RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

KÜÇÜKŞAHİN O., SATIŞ H., KARABULUT E., AYAN G., ERDEN A., BİLGİN E., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.1607, (Özet Bildiri)

8. AB0835 CANCER FREQUENCY IN CLOSE RELATIVES OF PATIENTS WITH SJÖGREN’S SYNDROME

Uğur Tuzcu T., KARDAŞ R. C., VASİ İ., YILDIRIM D., KAYA B., DURAN R., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.1715, (Özet Bildiri)

9. AB0394 COMORBIDITIES IN 40.643 PSORIATIC ARTHRITIS PATIENTS ACCORDING TO GENDER: RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

KALYONCU U., SATIŞ H., AYAN G., BİLGİN E., ERDEN A., ARMAĞAN B., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.1443-1444, (Özet Bildiri)

10. POS1514-HPR ASSOCIATION BETWEEN RESPIRATORY MUSCLE ENDURANCE WITH RESPIRATORY MUSCLE STRENGTH, EXERCISE CAPACITY, DYSPNEA, AND FATIGUE IN PATIENTS WITH RHEUMATOID ARTHRITIS

BAYRAM S., VASİ İ., ERDEN A., OSKAY D.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.1185-1186, (Özet Bildiri)

11. AB0397 CHARACTERISTICS OF PATIENTS WITH DIFFICULT TO TREAT PSORIATIC ARTHRITIS: RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

KALYONCU U., SATIŞ H., AYAN G., BİLGİN E., ERDEN A., ARMAĞAN B., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.1445-1446, (Özet Bildiri)

12. OP0175 COMORBIDITIES IN 347.902 RHEUMATOID ARTRITIS PATIENTS ACCORDING TO GENDER: RESULTS FROM E.PULSE, THE NATIONWIDE HEALTH DATA

KÜÇÜKŞAHİN O., SATIŞ H., KARABULUT E., AYAN G., ERDEN A., BİLGİN E., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.76-77, (Özet Bildiri)

13. AB1016 SERUM CXCL-13 LEVELS ARE ASSOCIATED WITH ACTIVE NEUROLOGICAL INVOLVEMENT IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

TUFAN A., YILDIRIM D., koç kanık h. n., DURAN R., KARDAŞ R. C., KAYA B., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.1826, (Özet Bildiri)

14. AB1421 DETERMINATION OF THE RELATIONSHIP BETWEEN SERUM PROTEIN 14-3-3 ETA LEVELS AND CLINICAL FEATURES OF THE DISEASE IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER

avcu a., YILDIRIM D., ERDEN A., KÜÇÜK H., TUFAN A., ÖZTÜRK M. A.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.2066, (Özet Bildiri)

15. AB1271 EVALUATION OF SINONASAL INVOLVEMENT IN ANCA-ASSOCIATED VASCULITIS USING THE SNOT-22 QUESTIONNAIRE

baş d., KARDAŞ R. C., YILDIRIM D., KAYA B., VASİ İ., DURAN R., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.83, ss.1979, (Özet Bildiri)

16. AB0041 EVALUATING DISEASE ACTIVITY AND CARDIOVASCULAR RISK USING BIOMARKERS IN FAMILIAL MEDITERRANEAN FEVER PATIENTS

YAZ AYDIN G., KARDAŞ R. C., VASİ İ., Altınsoy M. C., ERDEN A., KÜÇÜK H., et al.

European Congress of Rheumatology (EULAR) 2024, Viyana, Avusturya, 12 - 15 Haziran 2024, cilt.81, ss.1247, (Özet Bildiri)